Niva Bupa Health Insurance Ltd launched its IPO on November 7, 2024.
The Niva Bupa IPO is a book-built issue aiming to raise ₹2,200 crores, including a fresh issue of ₹800 crores and an offer for sale of ₹1,400 crores. Shares are offered at a price between ₹70 and ₹74 per share, with a minimum lot size of 200 shares. The IPO allotment is expected on November 12, with listing on the BSE and NSE set for November 14.
Niva Bupa Health Insurance IPO Timeline Details
| Detail | Information |
| IPO Opening Date | November 7, 2024 |
| IPO Closing Date | November 11, 2024 |
| Listing Date | November 14, 2024 |
| Face Value | ₹10 per share |
| Price Range | ₹70 to ₹74 per share |
| Lot Size | 200 shares |
| Maximum Bid Quantity for QII | 314285600 |
| Maximum Bid Quantity for NII | 78571400 |
| Total Issue Size | 31,42,85,714 |
| IPO Segment | Book Built Issue IPO |
| Book Running Lead Managers | ICICI Securities Limited, Axis Capital Limited, Morgan Stanley India Company Private Limited, HDFC Bank Limited, Kotak Mahindra Capital Company Limited, and Motilal Oswal Investment Advisors Limited |
| Sponsor Bank | Axis Bank Limited and HDFC Bank Limited |
| Listing At | BSE, NSE |
Niva Bupa Health Insurance Company Limited| Company Overview
Incorporated in 2008, Niva Bupa Health Insurance Ltd is a health insurance provider and a joint venture between the Bupa Group and Fettle Tone LLP. The company offers a range of health insurance products for individuals, families, and groups, as well as access to its Niva Bupa Health app for enhanced customer engagement.
Ready to Invest in Niva Bupa IPO? Open a free demat account and enjoy zero brokerage!
Key IPO Details
- Niva Bupa IPO Opening Date: November 7, 2024
- Niva Bupa IPO Closing Date: November 11, 2024
- Niva Bupa Allotment Date: November 12, 2024
- Niva Bupa IPO Price Band: ₹70 to ₹74 per share
- Niva Bupa IPO Lot Size: 200 shares
- IPO Refunds Initiated: November 13, 2024
- Shares Credited to Demat: November 13, 2024
- IPO Listing Date: November 14, 2024
Niva Bupa Health Insurance Ltd: Financial Highlights
Niva Bupa has shown strong growth, with its Gross Written Premium (GWP) increasing at a CAGR of 41.27% from FY 2022 to FY 2024.
| Year Ended | Assets (₹ Crore) | Revenue (₹ Crore) | Profit After Tax (₹ Crore) | Net Worth (₹ Crore) | Reserves and Surplus (₹ Crore) | Total Borrowing (₹ Crore) |
| 30 Jun 2024 | 6,542.06 | 1,124.90 | -18.82 | 2,031.77 | 1,282.44 | 250.00 |
| 31 Mar 2024 | 6,191.87 | 4,118.63 | 81.85 | 2,049.59 | 1,282.02 | 250.00 |
| 31 Mar 2023 | 3,876.57 | 2,859.24 | 12.54 | 831.12 | 334.26 | 250.00 |
| 31 Mar 2022 | 2,738.44 | 1,884.54 | -196.53 | 507.65 | 125.40 | 250.00 |
Niva Bupa Health Insurance IPO: SWOT Analysis
Should you invest in Niva Bupa health insurance IPO?
Here’s a look the overall company analysis:
Strengths:
- Extensive product range and strong brand reputation associated with Bupa.
- Advanced tech-driven customer service and CRM system.
- Strong presence across 22 states and four union territories in India.
- Consistent growth in GWP and active lives insured.
Weaknesses and Risks
- Reliance on a single market segment (health insurance).
- Vulnerability to regulatory changes in the insurance sector.
- High reliance on first-time customers may increase risk exposure.
Opportunities
- Opportunity to expand geographically and target a broader customer base.
- Potential for innovation in digital and tech-enabled customer solutions.
FAQs | Niva Bupa Health Insurance Ltd IPO
Niva Bupa Health Insurance Ltd provides a variety of health insurance products for retail and group clients in India.
The bidding date for the Niva Bupa IPO is from November 7, 2024, to November 11, 2024.
The IPO lot size for Niva Bupa is 200 shares.
The Niva Bupa IPO launch date is November 7, 2024, and it remains open for subscription until November 11, 2024.
You can check the IPO allotment status via the official registrar’s website.
The IPO allotment is expected to be finalized on November 12, 2024.
The IPO face value is set at ₹10 per share.
______________________________________________________________________________________
Disclaimer: Investments in the securities market are subject to market risks; read all the related documents carefully before investing.